Rodolfo Garza-Morales

12PUBLICATIONS
43CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursNeural engineeringMolecular targetsCharacterisation of biological macromolecules
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|May 27, 2026
RETRACTED: Garza-Morales et al. Targeting Melanoma Hypoxia with the Food-Grade Lactic Acid Bacterium Lactococcus lactis. Cancers 2020, 12, 438.

|Jul 15, 2025
Real-world outcomes of patients with aggressive B-cell lymphoma treated with epcoritamab or glofitamab.

Taylor R Brooks, Emily C Zabor, Yohanna B Bedelu

|Apr 13, 2024
Correction: Garza-Morales et al. Temozolomide Enhances Triple-Negative Breast Cancer Virotherapy In Vitro. Cancers 2018, 10, 144.

Rodolfo Garza-Morales, Roxana Gonzalez-Ramos, Akiko Chiba

|Mar 28, 2024
Oncolytic Adenovirus Armed with a Novel Agonist of the CD137 Immune Checkpoint Stimulator Suppresses Tumor Growth.

Martin R Ramos-Gonzalez, Mohammad Tarique, Lalit Batra

|Nov 21, 2022
Cerebrolysin induces hair repigmentation associated to MART-1/Melan-A reactivation.

Gustavo Villarreal-Reyna, Rodolfo Garza-Morales, Adolfo Soto-Domínguez

|Jul 27, 2022
Enhanced antitumor activity induced by a DNA vaccine encoding E7 antigen fused to an ERAD-targeting sequence.

David Hernán Martínez-Puente, Rodolfo Garza-Morales, José Juan Pérez-Trujillo

Pageof 2

Frequent Collaborators

7 joint publications

Jorge G Gomez-Gutierrez

4 joint publications

Maria J Loera-Arias

3 joint publications

Roberto Montes-de-Oca-Luna

2 joint publications

Mohammad Tariq Malik